A1C improvements curb 5-year mortality risk in diabetes

10/18/2012 | InternalMedicineNews.com

Data on 12,359 type 2 diabetes patients with poor glucose control revealed those who showed A1C improvements were less likely to die of any cause within five years compared with those who had no improvement in glucose levels. Participants with improved A1C were also less likely than those with poor glycemic control to develop coronary heart disease and experience fatal cardiovascular disease, researchers noted. The results were presented at the European Association for the Study of Diabetes meeting.

View Full Article in:

InternalMedicineNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC